STOCK TITAN

[8-K] SB Financial Group, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Copeland Capital Management, LLC, an investment adviser organized in Delaware, has filed a Schedule 13G indicating that it now holds a beneficial ownership of 676,795 shares of US Physical Therapy, Inc. (USPH) common stock, representing 5.85 % of the outstanding class as of 30 June 2025.

The firm reports:

  • Sole voting power: 583,323 shares
  • Shared voting power: 156,873 shares
  • Sole dispositive power: 583,323 shares
  • Shared dispositive power: 156,873 shares
The filing is made under Rule 13d-1(b) as Copeland qualifies as an investment adviser ("IA"). The certification is signed by Sofia A. Rosala, General Counsel & CCO, on 18 July 2025.

This disclosure signals that Copeland has crossed the 5 % reporting threshold, giving investors insight into evolving institutional ownership levels in USPH.

Copeland Capital Management, LLC, una società di consulenza agli investimenti con sede in Delaware, ha presentato un modulo Schedule 13G indicando di detenere ora una posizione beneficiaria di 676.795 azioni del capitale sociale ordinario di US Physical Therapy, Inc. (USPH), rappresentando il 5,85% della classe in circolazione al 30 giugno 2025.

La società riporta:

  • Potere di voto esclusivo: 583.323 azioni
  • Potere di voto condiviso: 156.873 azioni
  • Potere dispositivo esclusivo: 583.323 azioni
  • Potere dispositivo condiviso: 156.873 azioni
La comunicazione è effettuata ai sensi della Regola 13d-1(b), poiché Copeland si qualifica come consulente agli investimenti ("IA"). La certificazione è firmata da Sofia A. Rosala, Consigliere Generale e CCO, il 18 luglio 2025.

Questa divulgazione indica che Copeland ha superato la soglia di segnalazione del 5%, offrendo agli investitori una visione sull’evoluzione della proprietà istituzionale in USPH.

Copeland Capital Management, LLC, un asesor de inversiones organizado en Delaware, ha presentado un Schedule 13G indicando que ahora posee una propiedad beneficiaria de 676,795 acciones de acciones comunes de US Physical Therapy, Inc. (USPH), representando el 5.85% de la clase en circulación al 30 de junio de 2025.

La firma informa:

  • Poder de voto exclusivo: 583,323 acciones
  • Poder de voto compartido: 156,873 acciones
  • Poder dispositvo exclusivo: 583,323 acciones
  • Poder dispositvo compartido: 156,873 acciones
La presentación se realiza bajo la Regla 13d-1(b) ya que Copeland califica como un asesor de inversiones ("IA"). La certificación está firmada por Sofia A. Rosala, Consejera General y CCO, el 18 de julio de 2025.

Esta divulgación indica que Copeland ha superado el umbral de reporte del 5%, proporcionando a los inversionistas una visión sobre los niveles evolutivos de propiedad institucional en USPH.

Copeland Capital Management, LLC는 델라웨어에 설립된 투자 자문사로, Schedule 13G를 제출하여 현재 US Physical Therapy, Inc. (USPH) 보통주 676,795주에 대한 실질 소유권을 보유하고 있으며, 이는 2025년 6월 30일 기준 전체 발행 주식의 5.85%에 해당한다고 보고했습니다.

회사는 다음과 같이 보고합니다:

  • 단독 의결권: 583,323주
  • 공동 의결권: 156,873주
  • 단독 처분 권한: 583,323주
  • 공동 처분 권한: 156,873주
이 제출은 Copeland가 투자 자문사(IA)로 자격을 갖추었기 때문에 Rule 13d-1(b)에 따라 이루어졌습니다. 인증서는 2025년 7월 18일에 총괄 법률 고문 겸 최고 준법감시인인 Sofia A. Rosala가 서명했습니다.

이번 공시는 Copeland가 5% 보고 기준선을 넘었음을 의미하며, 투자자들에게 USPH 내 기관 소유권 변화에 대한 통찰을 제공합니다.

Copeland Capital Management, LLC, un conseiller en investissement organisé dans le Delaware, a déposé un Schedule 13G indiquant qu'il détient désormais une propriété bénéficiaire de 676 795 actions des actions ordinaires de US Physical Therapy, Inc. (USPH), représentant 5,85 % de la catégorie en circulation au 30 juin 2025.

La société rapporte :

  • Pouvoir de vote exclusif : 583 323 actions
  • Pouvoir de vote partagé : 156 873 actions
  • Pouvoir discrétionnaire exclusif : 583 323 actions
  • Pouvoir discrétionnaire partagé : 156 873 actions
Le dépôt est effectué en vertu de la Règle 13d-1(b) puisque Copeland se qualifie en tant que conseiller en investissement (« IA »). La certification est signée par Sofia A. Rosala, conseillère juridique générale et CCO, le 18 juillet 2025.

Cette divulgation indique que Copeland a franchi le seuil de déclaration de 5 %, offrant aux investisseurs un aperçu de l'évolution des niveaux de propriété institutionnelle dans USPH.

Copeland Capital Management, LLC, ein in Delaware gegründeter Investmentberater, hat einen Schedule 13G eingereicht, aus dem hervorgeht, dass er nun eine wirtschaftliche Eigentümerschaft von 676.795 Aktien der Stammaktien von US Physical Therapy, Inc. (USPH) hält, was 5,85 % der ausstehenden Aktienklasse zum 30. Juni 2025 entspricht.

Die Firma berichtet:

  • Alleiniges Stimmrecht: 583.323 Aktien
  • Gemeinsames Stimmrecht: 156.873 Aktien
  • Alleiniges Verfügungsrecht: 583.323 Aktien
  • Gemeinsames Verfügungsrecht: 156.873 Aktien
Die Meldung erfolgt gemäß Regel 13d-1(b), da Copeland als Investmentberater ("IA") qualifiziert ist. Die Bescheinigung wurde am 18. Juli 2025 von Sofia A. Rosala, General Counsel & CCO, unterzeichnet.

Diese Offenlegung signalisiert, dass Copeland die 5 %-Meldefrist überschritten hat und Investoren Einblick in die sich entwickelnden institutionellen Eigentumsverhältnisse bei USPH gibt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Copeland discloses 5.85 % USPH stake—material visibility but no control shift.

The new Schedule 13G shows Copeland Capital Management accumulating 676,795 USPH shares. Crossing the 5 % threshold is noteworthy because it can improve liquidity perception and may reflect confidence in USPH’s fundamentals. However, the filing is passive (13G, not 13D), so no activism intent is declared. Copeland retains largely sole voting/dispositive power, indicating centralized decision-making within the adviser. Absent additional context on purchase timing or cost basis, the impact remains informational rather than strategic.

Copeland Capital Management, LLC, una società di consulenza agli investimenti con sede in Delaware, ha presentato un modulo Schedule 13G indicando di detenere ora una posizione beneficiaria di 676.795 azioni del capitale sociale ordinario di US Physical Therapy, Inc. (USPH), rappresentando il 5,85% della classe in circolazione al 30 giugno 2025.

La società riporta:

  • Potere di voto esclusivo: 583.323 azioni
  • Potere di voto condiviso: 156.873 azioni
  • Potere dispositivo esclusivo: 583.323 azioni
  • Potere dispositivo condiviso: 156.873 azioni
La comunicazione è effettuata ai sensi della Regola 13d-1(b), poiché Copeland si qualifica come consulente agli investimenti ("IA"). La certificazione è firmata da Sofia A. Rosala, Consigliere Generale e CCO, il 18 luglio 2025.

Questa divulgazione indica che Copeland ha superato la soglia di segnalazione del 5%, offrendo agli investitori una visione sull’evoluzione della proprietà istituzionale in USPH.

Copeland Capital Management, LLC, un asesor de inversiones organizado en Delaware, ha presentado un Schedule 13G indicando que ahora posee una propiedad beneficiaria de 676,795 acciones de acciones comunes de US Physical Therapy, Inc. (USPH), representando el 5.85% de la clase en circulación al 30 de junio de 2025.

La firma informa:

  • Poder de voto exclusivo: 583,323 acciones
  • Poder de voto compartido: 156,873 acciones
  • Poder dispositvo exclusivo: 583,323 acciones
  • Poder dispositvo compartido: 156,873 acciones
La presentación se realiza bajo la Regla 13d-1(b) ya que Copeland califica como un asesor de inversiones ("IA"). La certificación está firmada por Sofia A. Rosala, Consejera General y CCO, el 18 de julio de 2025.

Esta divulgación indica que Copeland ha superado el umbral de reporte del 5%, proporcionando a los inversionistas una visión sobre los niveles evolutivos de propiedad institucional en USPH.

Copeland Capital Management, LLC는 델라웨어에 설립된 투자 자문사로, Schedule 13G를 제출하여 현재 US Physical Therapy, Inc. (USPH) 보통주 676,795주에 대한 실질 소유권을 보유하고 있으며, 이는 2025년 6월 30일 기준 전체 발행 주식의 5.85%에 해당한다고 보고했습니다.

회사는 다음과 같이 보고합니다:

  • 단독 의결권: 583,323주
  • 공동 의결권: 156,873주
  • 단독 처분 권한: 583,323주
  • 공동 처분 권한: 156,873주
이 제출은 Copeland가 투자 자문사(IA)로 자격을 갖추었기 때문에 Rule 13d-1(b)에 따라 이루어졌습니다. 인증서는 2025년 7월 18일에 총괄 법률 고문 겸 최고 준법감시인인 Sofia A. Rosala가 서명했습니다.

이번 공시는 Copeland가 5% 보고 기준선을 넘었음을 의미하며, 투자자들에게 USPH 내 기관 소유권 변화에 대한 통찰을 제공합니다.

Copeland Capital Management, LLC, un conseiller en investissement organisé dans le Delaware, a déposé un Schedule 13G indiquant qu'il détient désormais une propriété bénéficiaire de 676 795 actions des actions ordinaires de US Physical Therapy, Inc. (USPH), représentant 5,85 % de la catégorie en circulation au 30 juin 2025.

La société rapporte :

  • Pouvoir de vote exclusif : 583 323 actions
  • Pouvoir de vote partagé : 156 873 actions
  • Pouvoir discrétionnaire exclusif : 583 323 actions
  • Pouvoir discrétionnaire partagé : 156 873 actions
Le dépôt est effectué en vertu de la Règle 13d-1(b) puisque Copeland se qualifie en tant que conseiller en investissement (« IA »). La certification est signée par Sofia A. Rosala, conseillère juridique générale et CCO, le 18 juillet 2025.

Cette divulgation indique que Copeland a franchi le seuil de déclaration de 5 %, offrant aux investisseurs un aperçu de l'évolution des niveaux de propriété institutionnelle dans USPH.

Copeland Capital Management, LLC, ein in Delaware gegründeter Investmentberater, hat einen Schedule 13G eingereicht, aus dem hervorgeht, dass er nun eine wirtschaftliche Eigentümerschaft von 676.795 Aktien der Stammaktien von US Physical Therapy, Inc. (USPH) hält, was 5,85 % der ausstehenden Aktienklasse zum 30. Juni 2025 entspricht.

Die Firma berichtet:

  • Alleiniges Stimmrecht: 583.323 Aktien
  • Gemeinsames Stimmrecht: 156.873 Aktien
  • Alleiniges Verfügungsrecht: 583.323 Aktien
  • Gemeinsames Verfügungsrecht: 156.873 Aktien
Die Meldung erfolgt gemäß Regel 13d-1(b), da Copeland als Investmentberater ("IA") qualifiziert ist. Die Bescheinigung wurde am 18. Juli 2025 von Sofia A. Rosala, General Counsel & CCO, unterzeichnet.

Diese Offenlegung signalisiert, dass Copeland die 5 %-Meldefrist überschritten hat und Investoren Einblick in die sich entwickelnden institutionellen Eigentumsverhältnisse bei USPH gibt.

false 0000767405 0000767405 2025-07-21 2025-07-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) July 21, 2025 (July 21, 2025)

 

SB FINANCIAL GROUP, INC

(Exact name of registrant as specified in its charter)

 

Ohio   001-36785   34-1395608
(State or other jurisdiction
of incorporation)
 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

401 Clinton Street, Defiance, OH   43512
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (419) 783-8950

 

Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered

Common Shares, No Par Value 6,378,271 Outstanding at July 21, 2025

  SBFG  

The NASDAQ Stock Market, LLC

(NASDAQ Capital Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On July 21, 2025, SB Financial Group, Inc. (the “Company”) issued a press release announcing that its Board of Directors has declared a quarterly shareholder dividend of $0.15 per share. The dividend is payable on August 29, 2025 to all common shareholders of record as of August 15, 2025.

 

The information on this item 7.01, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall such information be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, except as otherwise stated in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(a) Not Applicable

 

(b) Not Applicable

 

(c) Not Applicable

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Press release issued by SB Financial Group, Inc. on July 21, 2025, announcing a quarterly shareholder dividend.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  SB FINANCIAL GROUP, INC.
     
Dated: July 21, 2025 By:  /s/ Anthony V. Cosentino
    Anthony V. Cosentino
Chief Financial Officer

 

2

 

 

INDEX TO EXHIBITS

 

Current Report on Form 8-K

Dated July 21, 2025

 

SB Financial Group, Inc.

 

Exhibit No.   Description
99.1   Press release issued by SB Financial Group, Inc. on July 21, 2025, announcing a quarterly shareholder dividend.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

Sb Finl Group Inc

NASDAQ:SBFG

SBFG Rankings

SBFG Latest News

SBFG Latest SEC Filings

SBFG Stock Data

125.35M
5.85M
10.2%
53.72%
1.78%
Banks - Regional
State Commercial Banks
Link
United States
DEFIANCE